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Brief Communication
F. van Kuppeveld, W. Melchers, J. Kissing, J. van der Logt, J. Galama
No Evidence of Mycoplasmas in Peripheral Blood Mononuclear Cell 
Fraction of HIV-Infected Patients
Summary: In this study, the prevalence of mycoplasmas in peripheral blood mononuclear 
cells (PBMC) from HIV-infected individuals was investigated using a mycoplasma genus- 
specific PCR assay. No mycoplasmas were detected in the PBMC samples from any of the 
25 HIV-infected individuals (CDC 2, n = 8; CDC 3, n = 2; CDC 4, n = 15) or ten HIV-sero­
negative controls. As an internal control, HIV specific sequences were detected in the sam­
ples from all HIV-seropositives. These negative results do not support a suggested role of 
mycoplasmas as co-factor in the progression of HIV infection towards AIDS.
Introduction
In HIV infection, functional defects and deletions in anti­
gen-reactive T cells have been reported to occur more fre­
quently than can be explained by direct viral infection. 
Therefore, it was suggested that a yet unidentified co-fac­
tor could play a role in the development of AIDS. Myco­
plasmas are considered as candidates for a role as co-fac­
tor. After the initial isolation of Mycoplasma incognitus, in 
fact a strain of Mycoplasma fermentans [1], from a patient 
with AIDS [2, 3], this organism has been found in blood, 
urine, organs and several other tissues of both AIDS pa­
tients and asymptomatic HIV-seropositive individuals 
[4-6]. Besides M. fermentans, also Mycoplasma genitali- 
um, Mycoplasma pirum and Mycoplasma penetrans have 
been isolated from HIV-infected individuals [7,8], A pos­
sible role of mycoplasmas as co-factor was suggested after 
in vitro studies with HIV-producing cell lines. In these 
studies it was demonstrated that mycoplasmas were able 
to fuse with T lymphocytes [9,10], that mycoplasmas en­
hanced the cytotoxic effects of HIV in cultures of T lym­
phocytes [11-13], and that elimination of mycoplasmas 
from HIV-producing cells prevented cell killing without 
affecting virus replication [14].
Whether mycoplasma infections simply represent oppor­
tunistic infections or whether they enhance the pathogeni­
city of HIV and play a role in the progression to AIDS is 
still unclear. To study the prevalance of mycoplasmas in 
PBMC of HIV-infected individuals, we tested PBMC from 
25 HIV-seropositives with different stages of disease pro­
gression by a mycoplasma genus-specific PCR assay [15].
Patients and Methods
The group of HIV-infected individuals consisted of 25 persons at­
tending the Department of Internal Medicine of the University 
Hospital Nijmegen. The CDC stages of the 25 HIV-infected indi­
viduals were CDC 2 (n = 8), CDC 3 (n = 2), and CDC 4 ( n = 15). 
The CD4+ T-cell numbers varied between 20 and 540 x 106/1 (me­
dian value: 130 x 106 CD4+ cells/1). Eighteen of these HIV-sero­
positives were homosexual men and two were intravenous drug 
users (one male and one female). Of the remaining five HIV-sero­
positives (four male and one female), risk factors were unknown. 
Ten healthy HIV-seronegative volunteers served as controls.
For PCR analysis, PBMC were isolated from 10 ml of citrated 
blood by standard Ficoll Hypaque density centrifugation [16]. 
Nucleic acid was isolated from 1 X 106 PBMC according to stan­
dard procedures [17], One \ ig  of nucleic acid was tested with the 
mycoplasma genus-specific primers (forward primer GPO-3, 
5' -GGGAGCAAACAGGATTAGATACCCT-3'; reverse prim­
er MGSO, 5'-TGCACCATCTGTCACTCTGTTAACCTC-3'), 
which amplify a 280 bp fragment [15]. These primers were se­
lected from 16S rRNA sequences and have been demonstrated to 
react with mycoplasmal members from each of the different phy­
logenetic subgroups [15]. The internal oligonucleotide probe 
GPO-4, 5' -CTT A A AGG A ATT G ACGGG A ACCCG -3' [15], 
was used for Southern blot hybridization. As internal control, 
10 |il of nucleic acid was tested with HIV-specific primers 
(primers SK 145 and SK 431; oligonucleotide probe SK 102; 
Perkin Elmer, Gouda, The Netherlands). Amplification by PCR 
and analysis of the amplified samples by agarose gel electropho­
resis and Southern blot hybridization were performed as 
previously described [18]. The thermal profile involved 40 cycles 
of denaturation at 94° C for 1 min, primer annealing at 55° C for 
1 min and primer extension at 72° C for 1 min.
Results
The PCR for mycoplasmas was negative for all PBMC 
samples of both the 25 HIV-infected individuals and the 
ten HIV-negative controls, while PBMC from an HIV- 
negative control spiked with mycoplasmas showed the 
280 bp amplification product (data not shown). HIV 
sequences were detected in the PBMC from all HIV-sero­
positives, which indicates that the negative PCR results 
obtained with the mycoplasma genus-specific primers are 
not due to inhibiting substances or to the quality of the 
nucleic acid.
Discussion
No mycoplasmas were detected in the PBMC fraction of 
any of the HIV-infected patients or seronegative controls. 
The CD4+ cell number as marker of disease progression in
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this study population of HIV-infected patients ranged be­
tween 20 and 540 X  106 cells/1, but no mycoplasmas were 
found. Thus, no evidence was found for a putative role of 
mycoplasmas in the progression of HIV infection towards 
AIDS. Hawkins et al. [19], Katseni et al. [20] and Bebear 
et al. [21], also found no correlation between the presence 
of M. fermentans and the clinical stage of HIV infection. In 
contrast to our study, however, these investigators found 
M. fermentans in 9-11% of the PBMC samples from both 
HIV-infected individuals and non-infected controls. It is 
not clear why M. fermentans was detected in approximate­
ly 10% of the individuals tested in these studies, while in 
our study all PBMC samples were negative for M. fermen­
tans as well as for other mycoplasmas. Recently, IgG anti­
bodies to M. penetrans were found at high frequencies in
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Zusammenfassung: Kein Nachweis von Mykoplasmen in der 
Fraktion peripherer mononukleärer Blutzellen bei HTV-infi- 
zierten Patienten. Bei HlV-infizierten Patienten wurde mit­
tels eines Genus-spezifischen PCR-Assay versucht, die Präva­
lenz von Mykoplasmen in mononukleären Zellen des peri­
pheren Blutes zu bestimmen. In keinem der 25 untersuchten 
Fälle (CDC-Stadium 2, n = 8; Stadium 3, n = 2; Stadium 4, n = 
15) und zehn HlV-seronegativen Kontrollen waren Myko­
plasmen in peripheren mononukleären Zellen nachzuweisen. 
In allen HlV-seropositiven Fällen waren HlV-spezifische Se­
quenzen mittels PCR nachzuweisen, was als interne Kontrol­
le dienen kann. Diese negativen Ergebnisse unterstützen die 
Hypothese nicht, daß Mykoplasmen eine Bedeutung als Ko­
faktoren der Progression der HlV-Infektion zu AIDS zu­
kommt.
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Book-Review ________ ___________
R. D. Feigin, J. D. Cherry (eds.)
Textbook of Pediatric Infectious Diseases (3rd edition)
Volumes 1 and 2, 2,395 pages plus index (87 pages), numerous 
figures and tables
W. B. Saunders Company, Philadelphia 1992 
Price: about $ 250,-
Eleven years after the publication of the first edition of the 
“Textbook of Pediatric Infectious Diseases” in 1981, the third 
edition of this well-known and internationally accepted refer­
ence book was published in late 1992.
Within the last decade, several new infectious diseases in chil­
dren have been described and novel infectious agents have been 
discovered so that a further extensive revision and expansion of 
the text was necessary and is appreciated by all specialists work­
ing in the field of pediatric infectious diseases. Furthermore, as 
the editors point out in their preface to this outstanding text­
book, the rapid progress of molecular biology and the develop­
ment of a new “molecular medicine“ have provided much infor­
mation for the understanding of infectious diseases. New diag­
nostic techniques have been established, and they have, for ex­
ample, led to the creation of recombinant hepatitis B vaccines, 
thus improving the prevention of a potentially severe viral infec­
tious disease in children and adults.
All medical progress in pediatric infectious diseases is documen­
ted by the contributions of 185 authors who wrote chapters on 
their specialty. The book is divided into seven major parts that 
contain 209 individual chapters of variable length. The first part, 
encompassing eight chapters, deals with general aspects of Host- 
Parasite Relationships and the Pathogenesis o f  Infectious D is­
eases. The extensive second part on the Infection o f  Specific Or­
gan Systems is divided into 15 sections according to the anatomi­
cal site or general appearance of infections. Starting with the dis­
cussion of upper and lower airway infections, this part ends with 
sections on opportunistic infections and the frequent clinical sit­
uation of fever of unknown origin. In part three, the most exten­
sive and central component of this textbook, all relevant specific 
microorganisms that cause infections in children are presented in
alphabetical order, in distinct chapters of eight sections (bacteri­
al infections, viral infections, chlamydial infections, rickettsial 
diseases, mycoplasma, fungal diseases, parasitic diseases and un­
classified infectious disease).
The other four parts of the book are shorter, but nevertheless 
very important and useful for clinical practice. Part four is titled 
Infection Control and is divided into two concise chapters on no­
socomial infections and the control of infections in the pediatric 
hospital. This important part of the book puts emphasis on the 
existence of active infection control teams in pediatric hospitals, 
as they are recommended by the Centers for Disease Control 
and widely accepted in the United States. The chapter on the 
control of infections contains an excellent comprehensive table 
on the required hospital precautions for patients with infectious 
diseases that may be used as a practical guideline.
Part five consists of two instructive chapters on antimicrobial and 
antiviral agents used for the therapy of pediatric infectious dis­
eases. Part six introduces concepts for the Prevention o f  Infec­
tious Diseases and explains the development and practice of ac­
tive immunizing agents and passive immunization. The final part 
of this outstanding textbook features A ids to the Diagnosis o f  In ­
fection with rather short chapters on the use of bacteriology, se­
rology and virology laboratories, and two closing chapters on 
rapid diagnostic techniques.
The book is organized in a systematic manner and is easy to 
handle when looking for specific information (despite the weight 
of the two volumes). It is very helpful that the extensive index 
appears at the end of both volumes. Each chapter of the book 
provides up to hundreds of relevant current and historical refer­
ences for further study of the literature.
It may be unnecessary to stress that the third edition of this well- 
established textbook may serve as an invaluable companion for 
all pediatricians and physicians whose main interest is focused on 
the broad field of pediatric infectious diseases. Taking into ac­
count the practical value of this two-volume set as a desk refer­
ence book, even the high price seems justifiable.
Michael Weiss 
München
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